Iqvia backs FY24 adjusted EPS view $10.95-$11.25, consensus $11.11

Lowers FY24 revenue view to $15.33B-$15.58B from $15.4B-$15.65B, consensus $15.53B. Backs FY24 adjusted EBITDA view $3.7B-$3.8B. The company said, “The company reaffirms its full-year revenue guidance on a constant currency basis. After adjusting for the $75 million impact of the strengthening US dollar since February 12, 2024, the revenue guidance is now $15,325 million to $15,575 million on a reported basis, resulting in growth of 2.3 to 3.9 percent. This guidance represents a year-over-year foreign exchange headwind of ~100 basis points, versus the ~50 basis points headwind included in the previous guidance. This guidance continues to assume approximately $300 million of COVID-related revenue step down as well as ~100 basis points of contribution from acquisitions.”